<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.5//EN" "ep-patent-document-v1-5.dtd">
<ep-patent-document id="EP00982308B8W1" file="EP00982308W1B8.xml" lang="en" country="EP" doc-number="1646395" kind="B8" correction-code="W1" date-publ="20141217" status="c" dtd-version="ep-patent-document-v1-5">
<SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIE......FI....CY..TR................................................</B001EP><B003EP>*</B003EP><B005EP>J</B005EP><B007EP>JDIM360 Ver 1.28 (29 Oct 2014) -  2999001/0</B007EP></eptags></B000><B100><B110>1646395</B110><B120><B121>CORRECTED EUROPEAN PATENT SPECIFICATION</B121></B120><B130>B8</B130><B132EP>B1</B132EP><B140><date>20141217</date></B140><B150><B151>W1</B151><B153>73</B153><B155><B1551>de</B1551><B1552>Bibliographie</B1552><B1551>en</B1551><B1552>Bibliography</B1552><B1551>fr</B1551><B1552>Bibliographie</B1552></B155></B150><B190>EP</B190></B100><B200><B210>00982308.9</B210><B220><date>20001130</date></B220><B240><B241><date>20020628</date></B241><B242><date>20071001</date></B242></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>168112 P</B310><B320><date>19991130</date></B320><B330><ctry>US</ctry></B330></B300><B400><B405><date>20141217</date><bnum>201451</bnum></B405><B430><date>20060419</date><bnum>200616</bnum></B430><B450><date>20141105</date><bnum>201445</bnum></B450><B452EP><date>20140513</date></B452EP><B480><date>20141217</date><bnum>201451</bnum></B480></B400><B500><B510EP><classification-ipcr sequence="1"><text>A61K  38/00        20060101AFI20060215BHEP        </text></classification-ipcr><classification-ipcr sequence="2"><text>A61K  38/16        20060101ALI20060215BHEP        </text></classification-ipcr><classification-ipcr sequence="3"><text>A61K  48/00        20060101ALI20060215BHEP        </text></classification-ipcr></B510EP><B540><B541>de</B541><B542>VERFAHREN UND ZUSAMMENSETZUNGEN ZUR REGULIERUNG DER LYMPHOZYTENAKTIVITÄT</B542><B541>en</B541><B542>METHODS AND COMPOSITIONS FOR REGULATING LYMPHOCYTE ACTIVITY</B542><B541>fr</B541><B542>METHODES ET COMPOSITIONS PERMETTANT DE REGULER L'ACTIVITE DES LYMPHOCYTES</B542></B540><B560><B561><text>WO-A-00/74706</text></B561><B561><text>WO-A1-98/30520</text></B561><B562><text>WILLIAMS K P ET AL: "FUNCTIONAL ANTAGONISTS OF SONIC HEDGEHOG REVEAL THE IMPORTANCE OF THE N TERMINUS FOR ACTIVITY" JOURNAL OF CELL SCIENCE, CAMBRIDGE UNIVERSITY PRESS, LONDON, GB, vol. 112, no. 22, 1999, pages 4405-4414, XP000918169 ISSN: 0021-9533</text></B562><B562><text>OUTRAM SUSAN V ET AL: "Hedgehog signaling regulates differentiation from double-negative to double-positive thymocyte" IMMUNITY, vol. 13, no. 2, August 2000 (2000-08), pages 187-197, XP002415875 ISSN: 1074-7613</text></B562><B562><text>EL ANDALOUSSI ABDELJABAR ET AL: "Hedgehog signaling controls thymocyte progenitor homeostasis and differentiation in the thymus" NATURE IMMUNOLOGY, vol. 7, no. 4, April 2006 (2006-04), pages 418-426, XP002415876 ISSN: 1529-2908</text></B562><B562><text>LIN J. ET AL.: 'Increased cAMP and cAMP-dependent protein kinase activity mediate anti-CD2 induced suppression of anti-CD3-driven interleukin-2 production and CD25 expression' vol. 63, September 1995, pages 175 - 187, XP002960939</text></B562><B565EP><date>20070205</date></B565EP></B560></B500><B700><B720><B721><snm>CROMPTON, Tessa</snm><adr><str>45A Wilberforce Road</str><city>London N4 2SP</city><ctry>US</ctry></adr></B721></B720><B730><B731><snm>Curis, Inc.</snm><iid>101223929</iid><irf>MGH/RJGPG432743</irf><adr><str>4 Maguire Road</str><city>Lexington, MA 02421</city><ctry>US</ctry></adr></B731></B730><B740><B741><snm>Horner, Martin Grenville</snm><sfx>et al</sfx><iid>100021629</iid><adr><str>Marks &amp; Clerk LLP 
Aurora 
120 Bothwell Street</str><city>Glasgow
G2 7JS</city><ctry>GB</ctry></adr></B741></B740></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>IE</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LU</ctry><ctry>MC</ctry><ctry>NL</ctry><ctry>PT</ctry><ctry>SE</ctry><ctry>TR</ctry></B840><B860><B861><dnum><anum>US2000032590</anum></dnum><date>20001130</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO2001040438</pnum></dnum><date>20010607</date><bnum>200123</bnum></B871></B870></B800></SDOBI>
</ep-patent-document>
